All Relations between dopaminergic and neurotransmitter

Publication Sentence Publish Date Extraction Date Species
Angela Bronte, Elena Prieto, Gemma Quincoces, Elena Erro, Javier Arbiz. The basics of PET molecular imaging in neurodegenerative disorders with dementia and/or parkinsonism. European radiology. 2025-02-07. PMID:39918781. moreover, we will revise pet tracers targeting neurotransmitter systems such as the dopaminergic system which can detect early functional changes in movement disorders. 2025-02-07 2025-02-09 Not clear
Junia Lara de Deus, Juliana Marino Maia, Renato Nery Soriano, Mateus R Amorim, Luiz G S Branc. Psychedelics in neuroinflammation: Mechanisms and therapeutic potential. Progress in neuro-psychopharmacology & biological psychiatry. 2025-02-01. PMID:39892847. beyond the serotonergic system, other neurotransmitter systems-including the glutamatergic, dopaminergic, noradrenergic, gamma-aminobutyric acid (gabaergic), and cholinergic systems-also play significant roles in mediating the effects of psychedelics. 2025-02-01 2025-02-04 Not clear
Frederik O Hansen, Karoline Knudsen, Malene F Damholdt, Toke Bek, Per Borghammer, Niels Okkel. Non-motor asymmetry and dopamine degeneration in Parkinson's disease. Brain communications. vol 7. issue 1. 2025-01-23. PMID:39845733. given the impact of lewy pathology on various neurotransmitter systems beyond the dopaminergic, it may be that other neuronal systems in the predominantly affected hemisphere are similarly affected. 2025-01-23 2025-01-25 Not clear
Frederik O Hansen, Karoline Knudsen, Malene F Damholdt, Toke Bek, Per Borghammer, Niels Okkel. Non-motor asymmetry and dopamine degeneration in Parkinson's disease. Brain communications. vol 7. issue 1. 2025-01-23. PMID:39845733. according to this hypothesis, asymmetry in dopaminergic degeneration would be expected to coincide with asymmetry in other neurotransmitter systems. 2025-01-23 2025-01-25 Not clear
Mukesh Kumar, Aminu Aliyar, Arti Saini, Sridhar Sivasubbu, Vinod Scaria, Divya M Radhakrishnan, Roopa Rajan, Binukumar B. Unprecedented Co-occurrence: Identification of a Pathogenic Genetic Variant in the KMT2B Gene in a Wilson Disease Patient with a Pathogenic ATP7B Mutation. Annals of neurosciences. vol 31. issue 4. 2025-01-22. PMID:39840144. copper accumulation in the basal ganglia, disrupts dopaminergic pathways, contributing to dystonia's development via neurotransmitter imbalance. 2025-01-22 2025-01-24 Not clear
Haigang Chang, Yaxiao Wang, Lei Hui, Yuling Diao, Pengju Ma, Xiangsheng Li, Feng Wan. iTRAQ proteomic analysis of the anterior insula in morphine-induced conditioned place preference rats with high-frequency deep brain stimulation intervention. Addiction biology. vol 30. issue 1. 2025-01-21. PMID:39835462. based on gene ontology enrichment an kegg pathway analyses, the majority of these differentially expressed proteins (deps) were involved in protein metabolic process, g-protein coupled receptor signalling pathway, calcium-mediated signalling, neurotransmitter transport, dopaminergic synapse and mtor signalling pathway. 2025-01-21 2025-01-23 rat
Hajira Umer, Ali Sharif, Humaira Majeed Khan, Syed Muhammad Muneeb Anjum, Bushra Akhtar, Sajid Ali, Muhammad Ali, Muhammad Asif Hani. Mitigation of Neuroinflammation and Oxidative Stress in Rotenone-Induced Parkinson Mouse Model through Liposomal Coenzyme-Q10 Intervention: A Comprehensive In-vivo Study. Inflammation. 2025-01-21. PMID:39836283. motor performance, the preservation of dopaminergic neurons, levels of neuroinflammation, oxidative stress, neurotransmitter levels, rt-qpcr analysis of pd-linked genes and histopathology were evaluated. 2025-01-21 2025-01-23 mouse
Emma D Frost, Swanny X Shi, Vishnu V Byroju, Jamir Pitton Rissardo, Jack Donlon, Nicholas Vigilante, Briana P Murray, Ian M Walker, Andrew McGarry, Thomas N Ferraro, Khalid A Hanafy, Valentina Echeverria, Ludmil Mitrev, Mitchel A Kling, Balaji Krishnaiah, David B Lovejoy, Shafiqur Rahman, Trevor W Stone, Maju Mathew Kool. Galantamine-Memantine Combination in the Treatment of Parkinson's Disease Dementia. Brain sciences. vol 14. issue 12. 2025-01-08. PMID:39766362. pd has several derangements in neurotransmitter pathways (dopaminergic neurons in the nigrostriatal pathway, kynurenine pathway (kp), acetylcholine, α7 nicotinic receptor, and n-methyl-d-aspartate (nmda) receptors) and rivastigmine is only partially effective as it only targets one pathway. 2025-01-08 2025-01-13 Not clear
Maximiliano Abarca, Humberto Pizarro, M Leonor Bustamante, Gustav Rohde, Marcelo Arancibi. Genetic and neurobiological aspects of psychosis in major neurocognitive disorder. Medwave. vol 25. issue 1. 2025-01-08. PMID:39772397. on the other hand, alterations of the cholinergic, serotonergic, dopaminergic, and gabaergic neurotransmitter systems and the excitatory-inhibitory balance have been described in dementia. 2025-01-08 2025-01-13 Not clear
Eman A Fayed, Samiha Ahmed El-Sebaey, Maha A Ebrahim, Karema Abu-Elfotuh, Reda El-Sayed Mansour, Ehsan Khedre Mohamed, Ahmed M E Hamdan, Faleh Turki Al-Subaie, Gharam Saad Albalawi, Tariq Mohammed Albalawi, Amira M Hamdan, Asmaa A Mohammed, Triveena M Ramsi. Discovery of novel bicyclic and tricyclic cyclohepta[b]thiophene derivatives as multipotent AChE and BChE inhibitors, in-Vivo and in-Vitro assays, ADMET and molecular docking simulation. European journal of medicinal chemistry. vol 284. 2024-12-28. PMID:39731791. changes in dopaminergic and serotoninergic neurotransmitter pathways are linked to certain symptoms of ad. 2024-12-28 2024-12-31 Not clear
Atsushi Fujimoto, Catherine Elorette, Satoka H Fujimoto, Lazar Fleysher, Peter H Rudebeck, Brian E Rus. Pharmacological modulation of dopamine receptors reveals distinct brain-wide networks associated with learning and motivation in non-human primates. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2024-12-27. PMID:39730205. the neurotransmitter dopamine (da) has a multifaceted role in healthy and disordered brains through its action on multiple subtypes of dopaminergic receptors. 2024-12-27 2024-12-30 human
Mayur B Kale, Nitu L Wankhede, Barkha K Goyanka, Reena Gupta, Ashok Kumar Bishoyi, Deepak Nathiya, Parjinder Kaur, Kumari Shanno, Brijesh G Taksande, Mohammad Khalid, Aman B Upaganlawar, Milind J Umekar, Monica Gulati, Monika Sachdeva, Tapan Behl, Amin Gasm. Unveiling the Neurotransmitter Symphony: Dynamic Shifts in Neurotransmitter Levels during Menstruation. Reproductive sciences (Thousand Oaks, Calif.). 2024-11-19. PMID:39562466. menstruation is characterized by declining estrogen and progesterone, potentially leading to mood disturbances, fluctuating gabaergic and dopaminergic neurotransmitter systems, relaxation, fatigue, motivation, and pleasure variations. 2024-11-19 2024-11-23 Not clear
Martina Cuccarelli, Alessandro Zampogna, Antonio Supp. The broad spectrum of malignant syndromes. Neurobiology of disease. 2024-11-14. PMID:39542220. while distinct mechanisms may initially trigger the different malignant syndromes, a final common pathway leading to similar signs and symptoms involves various neurotransmitter systems, including dopaminergic, serotonergic, gabaergic, glycinergic, and glutamatergic pathways. 2024-11-14 2024-11-17 Not clear
Anthony Radzimirski, Michael Croft, Nicholas Ireland, Lydia Miller, Jennifer Newell-Caito, Samuel Cait. Dopaminergic- and Serotonergic-Dependent Behaviors Are Altered by Lanthanide Series Metals in Toxics. vol 12. issue 10. 2024-10-26. PMID:39453174. as dysfunctions of serotonergic and dopaminergic signaling are implicated in multiple neurological conditions, including parkinson's disease, depression, generalized anxiety disorder, and post-traumatic stress disorder, it is of utmost importance to determine the effects of la and other lanthanides on these neurotransmitter systems. 2024-10-26 2024-10-28 Not clear
Huize Pang, Xiaolu Li, Ziyang Yu, Hongmei Yu, Shuting Bu, Juzhou Wang, Mengwan Zhao, Yu Liu, Yueluan Jiang, Guoguang Fa. Disentangling gray matter atrophy and its neurotransmitter architecture in drug-naïve Parkinson's disease: an atlas-based correlation analysis. Cerebral cortex (New York, N.Y. : 1991). vol 34. issue 10. 2024-10-18. PMID:39420471. parkinson's disease is characterized by multiple neurotransmitter systems beyond the traditional dopaminergic pathway, yet their influence on volumetric alterations is not well comprehended. 2024-10-18 2024-10-20 Not clear
Yuhan Zhang, Yuan Liang, Yixue G. The dopaminergic system and Alzheimer's disease. Neural regeneration research. 2024-09-24. PMID:39314145. in addition to the most widely accepted causes, which include excessive aβ aggregation, tau hyperphosphorylation, and deficiency of the neurotransmitter acetylcholine, numerous studies have shown that the dopaminergic system is also closely associated with the occurrence and development of this condition. 2024-09-24 2024-09-26 human
Chae Yeon Kim, Yunseo Park, Jong Young Namgung, Yeongjun Park, Bo-Yong Par. The macroscale routing mechanism of structural brain connectivity related to body mass index. Human brain mapping. vol 45. issue 13. 2024-09-04. PMID:39230183. the neurotransmitter association analysis identified that serotonergic and dopaminergic receptors, as well as opioid and norepinephrine systems, were related to bmi-related alterations in navigation efficiency. 2024-09-04 2024-09-06 Not clear
Ashini Singh, Suman Sinha, Niraj Kumar Sing. Dietary Natural Flavonoids: Intervention for MAO-B Against Parkinson's Disease. Chemical biology & drug design. vol 104. issue 3. 2024-09-03. PMID:39223743. the precise etiology of pd remains elusive, but recent research has shed light on potential factors, including the formation of α-synuclein aggregates, oxidative stress, neurotransmitter imbalances, and dopaminergic neurodegeneration in the substantia nigra pars compacta (snpc) region of the brain, culminating in motor symptoms such as bradykinesia, akinesia, tremors, and rigidity. 2024-09-03 2024-09-05 Not clear
Heng Chen, Jieshu Li, Zhixing Huang, Xiaoxiao Fan, Xiaofei Wang, Xing Chen, Haitao Guo, Hao Liu, Shuqi Li, Shaojun Yu, Honghong Li, Xinyu Huang, Xuehua Ma, Xinqi Deng, Chunguo Wang, Yonggang Li. Dopaminergic system and neurons: Role in multiple neurological diseases. Neuropharmacology. vol 260. 2024-08-30. PMID:39197818. the dopaminergic system is a complex and powerful neurotransmitter system in the brain. 2024-08-30 2024-09-01 human
Manuel Glauco Carbone, Icro Maremman. Chronic Cocaine Use and Parkinson's Disease: An Interpretative Model. International journal of environmental research and public health. vol 21. issue 8. 2024-08-29. PMID:39200714. specifically, we supposed that the chronic administration of cocaine produces significant neurobiological changes, causing a complex dysregulation of various neurotransmitter systems, mainly affecting subcortical structures and the dopaminergic pathways. 2024-08-29 2024-09-01 human